A
AstraZeneca Pharma
ASTRAZEN Share Price
Healthcare8,487.00
as on 09 Mar 2026 at 11:06
Market Cap
₹21,218 Cr
PE Ratio
108.80
ROCE
19.36%
ASTRAZEN Fundamentals
Company Valuation
Market Cap (₹ Cr.)
21,218
PE Ratio
108.80
PB Ratio
27.35
Dividend Yield
0.37%
ROE
15.02%
ROCE
19.36%
Book Value (₹)
319.60
Face Value (₹)
2.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% |
| Domestic Institutional Investors (DII) | 5.22% | 4.65% | 4.56% | 5.26% | 5.56% |
| Foreign Institutional Investors (FII) | 2.93% | 2.89% | 3.03% | 2.74% | 2.71% |
| Public Investors | 14.62% | 15.16% | 15.18% | 14.39% | 14.14% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
ASTRAZEN Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Smallcap
BSE Scrip Code
506820
NSE Scrip Name
ASTRAZEN
ISIN
INE203A01020



